Last reviewed · How we verify
Punctate keratopathy
Approved treatments
- Fml · AbbVie
- Medrifar · AbbVie
- Cortone
- Decadron · Generic (originally Merck)
- Cortef · Generic (originally Merck/Upjohn)
- Flarex · Harrow Health
- Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Punctate keratopathy patent landscape — cliff calendar, originator estates, attackable patents
- Punctate keratopathy treatment landscape brief
- Punctate keratopathy treatment updates RSS
Frequently asked questions about Punctate keratopathy
What drugs treat Punctate keratopathy?
Tracked treatments include Fml, Medrifar, Cortone, Decadron, Cortef, Flarex, Cortisol, Prelone.
What is the treatment for Punctate keratopathy?
Standard treatment for Punctate keratopathy includes Fml, Medrifar, Cortone, Decadron, Cortef. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Punctate keratopathy patent cliff · Punctate keratopathy CI report
- Treatment: Fml · AbbVie
- Treatment: Medrifar · AbbVie
- Treatment: Cortone
- Treatment: Decadron · Generic (originally Merck)
- Treatment: Cortef · Generic (originally Merck/Upjohn)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing